InsidersTradesSigma
ALK-Abelló: insider trades · Denmark · Finanstilsynet DK
DK:alk-abelloDK0060027142DK·Finanstilsynet DKMcap 55.4Bn€Healthcare
Discover the full insider trade history of ALK-Abelló, a listed equity based in Denmark. Shares are quoted on DK DK, under the authority of Finanstilsynet DK. Operating in the Healthcare sector, ALK-Abelló has recorded 35 insider filings. Market capitalisation: €55.4bn. The latest transaction was filed on 21 March 2019 — Other. Among the most active insiders: Unknown. All data is free.
35
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
250.20 €
Analyst consensus
3 analystsStrong buy
285.00 €Target 295.00 €(+18%)300.00 €
Income statement
Revenue6.31 Bn€
Gross profit4.23 Bn€67% margin
Net income1.20 Bn€19.5% margin
Valuation
PER (trailing)43.2x
PER (forward)33.3x
P/Book8.4x
Beta0.68
Balance sheet & cash
Market cap55.44 Bn€
Total debt418.0 M€
Free Cash Flow1.46 Bn€
Debt / Equity6%
Profitability & ownership
ROE20.9%
ROA12.6%
% insiders0.0%
% institutions61.9%
Last declaration on 21 March 2019
Declarations35 total
25 of 35 declarations
About ALK-Abelló
ALK-Abelló is a company focused on developing treatments for allergies, particularly immunotherapies. It is listed on the XCSE exchange.